Four commonly used vaporizers were studied for the effect of carrier gas density on vaporizer output. Vapour concentrations from a halothane Cyprane (Fluotec) Mark 2 increased in relation to the density of carrier gas, whereas the concentrations delivered by an enflurane Ohio vaporizer decreased. The halothane Cyprane (Fluotec) Mark 3 and enflurane Cyprane vaporizers were largely independent of density. Of clinical importance, nitrous oxide/oxygen (75/25), compared with oxygen alone, increased the vapour concentration outputs of the halothane Mark 2 up to 30 per cent and decreased the outputs of the enflurane Ohio unit up to 20 per cent.
PREVIOUS OBSERVATIONS suggest that the anaesthetic outputs of commonly used vaporizers vary with the composition of carrier gas L2. Nitrous oxide, 60 to 70 per cent with oxygen, was reported to increase the vapour concentration outputs of a halothane vaporizer (Cyprane MK.2) t and two enflurane vaporizers (Ohio and Cyprane) z. These effects were attributed to redistribution of flow resistances within these vaporizers by increased carrier gas density.
To explore further the hypothesis that vaporizer function depends upon the density of carrier gas, we measured the output responses of four commonly used vaporizers to carrier gases of widely varying density and viscosity.
METHODS
The four vaporizers studied were two models of the Cyprane (Fluotec) halothane vaporizer, the Mark 2 and Mark 3, and the enflurane vaporizers manufactured by Ohio and Cyprane. All four units had been calibrated recently by the manufacturer. Each vaporizer was placed on a flat surface and fitted with a rigid metal extension incorporating a sampling poll 35 cm distal to the vaporizer outlet.
For this study, we selected carrier gases and carrier gas mixtures which have a wide range of gas density; these were helium with oxygen (50150), nitrogen, oxygen, carbon dioxide with oxygen (10/90), nitrous oxide with oxygen (80/20), nitrous oxide and SF6 with nitrous oxide (9.5/90.5), Each gas or gas mixture was delivered from calibrated rotameters set to give a total flow rate of 6 l/min, this rate having been verified by a timed collection of gas with a Collins watersealed spirometer.
Carrier gases were introduced suddenly into the inlet of each vaporizer and kept constant while outlet vapour concentrations were measured at dial settings of 0.5, 1.0, 1.5, 2.0, 2.5 and 3.0 per cent. Vapour concentrations were recorded two to three minutes after establishing each condition of carrier gas and dial setting; in preliminary studies we found that changes in vaporizer output were always complete within 120 seconds and remained stable for at least 30 minutes.
The concentrations of both vapours (halothane and enflurane) and all carrier gases except helium were measured by a Perkin-Elmer #1100 mass spectrometer. Helium cannot be analyzed in our laboratory and its concentration was only inferred from rotameter settings. Vapour concentrations in the helium/oxygen mixture were determined by a Beckman infrared analyzer with a halothane pickup head purged with helium/oxygen (50/50). Both mass spectrometer and infrared analyzers were calibrated on each testing day with certified test gases and vapours (Canadian Liquid Air for carrier gases and Scott's Specialty Gases for halothane and enflurane). Gas densities and viscosities were found in standard tables of physical characteristics of gases. 
RESULTS
The vapour outputs of the halothane Cyprane (Table ll) do not refer to changes in vapour concentration (which is determined in part by barometric pressure per se because it is equiv- alent to the ratio of vapour pressure to barometric pressure), but rather to changes in absolute vapour partial pressure.
DISCUSSION
Stoelting observed that the halothane concentrations delivered by a Cyprane (Fluotec) Mark 2 vaporizer were markedly affected by either nitrous oxide or helium in the carrier gas.~ Compared with oxygen, nitrous oxide increased the ouput of this vaporizer at dial settings of 0. I, 0.5 and 1.0 per cent, while helium in carrier gas reduced output. These phenomena were considered to be related to the density of the carrier gas (nitrous oxide more dense and helium less dense than oxygen), with density affecting the relative flow-resistances of by-pass and vaporizing chamber channels and thus the proportion of flow to the vaporizing chamber and vaporizer output.t Paterson, et al. had previously observed that the outputs of the newer halothane Cyprane (Fluotec) Mark 3 model did not share this dependence upon carrier gas composition, at least with respect to nitrous oxide: Recently, Nawaf and Stoelting reported that the enflurane vaporizers manufactured by Ohio and Cyprane both increased their outputs when nitrous oxide was included in the carrier gas, presumably by a density mechanism akin to that proposed for the halothane Cyprane Mark 2. 2 The purpose of the present study was to examine vaporizer responses to a wider variation in carrier gas composition and properties, in order to magnify and better to quantitate any density or viscosity related effects.
In agreement with the previous studies of the halothane.Cyprane vaporizers,"4 we found that nitrous oxide compared with oxygen clearly increased the output of the Mark 2 model, while having little or no effect on the Mark 3 at dial settings below three per cent ( Figure 1, Figure 2 ). The magnitudes of nitrous oxide effect we observed concur closely with the data presented in the previous reports. TM Our additional finding that the outputs of the Mark 2 model varied in direct relation to the gas densities of seven different gases orgas mixtures supports the hypothesis of a density-related mechanism. We suspect that increased carrier gas density in the Mark 2 increases vaporizer output by increasing the proportion of gas flow through the vaporizing chamber, as a result of augmented resistance to flow in the by-pass channel (regulated by the con S centration control valve). This assumes that bypass flow resistance is more density dependent (i.e. turbulent) than vaporizer chamber resistance, a not unreasonable assumption considering the structure of this unit: The Mark 3 model probably behaves in a "'density-independent" fashion because of a different arrangement of internal resistances) In this unit, there are restrictions to carrier gas flow (controlled by the concentration control valve) at the inlet of the by-pass channel and at both the inlet and outlet of the vaporizing channel, all of which are probably density-dependent. Thus, any changes in flow resistance due to density might well be distributed proportionately between by-pass and vaporizing channels, making the division of gas flow between the two, and thus vaporizer output, density independent.
The present study does not confirm the observations of Nawaf that nitrous oxide increases the output of both the enflurane Ohio and enflurane Cyprane vaporizers. With respect to the Ohio unit, we observed that nitrous oxide reduced output and that output generally varied inversely with gas density over the range of gas densities we tested (Figure 3) . The enflurane Cyprane vaporizer was found to be carrier gas independent (Figure 4) . The basis for the differences between these results and those of Nawafis not clear. The construction of the Ohio unit is such that carrier gas flow is diverted into three channels; an open by-pass channel of fixed dimensions, a by-pass channel whose resistance is controlled by the concentration adjust valve and a vaporizer chamber inlet in which resistance is also controlled by the concentration adjust valve.* We explain our results by hypothesizing that the flow resistance of the concentration adjust valve is dependent upon gas density, so that as density increases the proportion of flow through the fixed by-pass channel increases and, therefore, the vaporizer output decreases. One would expect this effect to be most pronounced at the lower settings, when the resistance to the vaporizer inlet channel is the greatest and this, indeed, is what we observed (Figure 3 ). The construction of the Cyprane enflurane vaporizer is nearly identical to that of the halothane Cyprane Mark 3 discussed above and the basis for the densityindependence of each is likely the same.
Our results indicate that the amount of vapour emerging from a halothane Cyprane Mark 2 or Ohio enflurane vaporizer is affected by the density of carrier gases. Factory calibration of the dial settings of these vaporizers employs 100 per cent oxygen as the carrier gas (density 1.43 g-litre-~); gases of different density will give a vapour concentration somewhat different than that indicated by the dial. This effect will be important when nitrous oxide is included in the carrier gas and/or when density is increased by hyperbaric pressures.
Predicted magnitudes of nitrous oxide effect on the output of both density-dependent vaporizers are given in Table I . In the clinical setting, addition of nitrous oxide to the halothane Cyprane Mark 2 at a fixed dial setting increases overall anaesthetic potency in three ways; first, by the added anaesthetic effect of nitrous oxide per se; secondly, by augmenting the fresh gas concentration of halothane through the vaporizer-gas density effect; and thirdly, by further increasing the alveolar level of halothane through the second gas effect. When nitrous oxide is added to the carrier gas of the Ohio enflurane vaporizer, the increased anaesthetic potency resulting from the first and third of these effects would be partially offset by reduced enflurane concentrations emerging from the vaporizer.
Increased ambient pressure increases gas density and in that way might be expected to alter the function of density dependent vaporizers. McDowall reported that two atmospheres of ambient pressure increased the output of the halothane Cyprane Mark 2. 7 Our predictions of the effects of hyperbaric pressure are presented in Table II and those for the Mark 2 concur with McDowall's observations. 7
